Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 412158, 9 pages
http://dx.doi.org/10.1155/2014/412158
Research Article

Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves’ Orbitopathy: Clinical Implications

1Department of Medical Pathomorphology, Cathedral of Biostructure, Medical University of Białystok, 13 Waszyngtona Street, 15-269 Białystok, Poland
2Department of Pediatric Ophthalmology with Strabismus Treatment Unit, Medical University of Białystok, 17 Waszyngtona Street, 15-274 Białystok, Poland
3Department of Ophthalmology, University Hospital Essen and University of Duisburg-Essen, Hufeland Straße 55, 45-122 Essen, Germany
4Bayer Healtcare, Kaiser-Wilhelm-Allee 10, Leverkusen, 51-373 Nordshein-Westfalen, Germany
5Department of Ophthalmology, Poznań City Hospital, 3 Szwajcarska Street, 61-285 Poznań, Poland
6Department of Ophthalmology, University of Warmia and Mazury, 30 Warszawska Street, 10-082 Olsztyn, Poland
7Department of Nuclear Medicine, Medical University of Białystok, 24A Skłodowskiej-Curie Street, 15-276 Białystok, Poland

Received 16 May 2014; Revised 6 August 2014; Accepted 9 August 2014; Published 17 September 2014

Academic Editor: Valentin Huerva

Copyright © 2014 Przemyslaw Pawlowski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. K. Eckstein, K. T. Johnson, M. Thanos, J. Esser, and M. Ludgate, “Current insights into the pathogenesis of Graves' orbitopathy.,” Hormone and Metabolic Research, vol. 41, no. 6, pp. 456–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. S. Prabhakar, R. S. Bahn, and T. J. Smith, “Current perspective on the pathogenesis of Graves' disease and ophthalmopathy,” Endocrine Reviews, vol. 24, no. 6, pp. 802–835, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. N. I. Regensburg, W. M. Wiersinga, T. T. J. M. Berendschot, P. Potgieser, and M. P. Mourits, “Do subtypes of graves' orbitopathy exist?” Ophthalmology, vol. 118, no. 1, pp. 191–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. W. M. Wiersinga and L. Bartalena, “Epidemiology and prevention of Graves' ophthalmopathy,” Thyroid, vol. 12, no. 10, pp. 855–860, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. E. Heufelder, “Pathogenesis of ophthalmopathy in autoimmune thyroid disease,” Reviews in Endocrine and Metabolic Disorders, vol. 1, no. 1-2, pp. 87–95, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. R. S. Bahn, “Graves' ophthalmopathy,” The New England Journal of Medicine, vol. 362, no. 8, pp. 726–738, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Pappa, J. M. Lawson, V. Calder, P. Fells, and S. Lightman, “T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy,” British Journal of Ophthalmology, vol. 84, no. 5, pp. 517–522, 2000. View at Google Scholar
  8. P. Pawlowski, J. Mysliwiec, A. Stasiak-Barmuta, A. Bakunowicz-Lazarczyk, and M. Gorska, “Increased percentage of L-selectin+ and ICAM-1+ peripheral blood CD4+/CD8+ T cells in active Graves' ophthalmopathy,” Folia Histochemica et Cytobiologica, vol. 47, no. 1, pp. 29–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. I. M. Wakelkamp, O. Bakker, L. Baldeschi, W. M. Wiersinga, and M. F. Prummel, “TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients,” Clinical Endocrinology, vol. 58, no. 3, pp. 280–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. E. Feldon, C. W. O'Loughlin, D. M. Ray, S. Landskroner-Eiger, K. E. Seweryniak, and R. P. Phipps, “Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes,” The American Journal of Pathology, vol. 169, no. 4, pp. 1183–1193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kazim, R. A. Goldberg, and T. J. Smith, “Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy,” Archives of Ophthalmology, vol. 120, no. 3, pp. 380–386, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Koumas, T. J. Smith, S. Feldon, N. Blumberg, and R. P. Phipps, “Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes,” American Journal of Pathology, vol. 163, no. 4, pp. 1291–1300, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Wang and T. J. Smith, “Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy,” Investigative Ophthalmology & Visual Science, vol. 55, no. 3, pp. 1735–1748, 2014. View at Google Scholar
  14. J. Mysliwiec, I. Palyga, A. Nikolajuk, A. Kowalska, and M. Gorska, “Serum interleukin-16 and RANTES during treatment of Graves' orbitopathy with corticosteroids and teleradiotherapy,” Endokrynologia Polska, vol. 63, no. 2, pp. 92–96, 2012. View at Google Scholar · View at Scopus
  15. E. B. Y. Konuk, O. Konuk, M. Misirlioglu, A. Menevse, and M. Unal, “Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of Graves' ophthalmopathy patients,” European Journal of Endocrinology, vol. 155, no. 5, pp. 681–685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Vondrichova, A. de Capretz, H. Parikh et al., “COX-2 and SCD, markers of inflammation and adipogenesis, are related to disease activity in Graves' ophthalmopathy,” Thyroid, vol. 17, no. 6, pp. 511–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Matos, P. G. Manso, E. Marback, R. Furlanetto, G. N. Alberti, and V. Nosé, “Protein expression of VEGF, IGF-1 and FGF in retro-ocular connective tissues and clinical correlation in Graves' ophthalmopathy,” Arquivos Brasileiros de Oftalmologia, vol. 71, no. 4, pp. 486–492, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. P. Mourits, M. F. Prummel, W. M. Wiersinga, and L. Koornneef, “Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy,” Clinical Endocrinology, vol. 47, no. 1, pp. 9–14, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. P. J. Dolman, “Evaluating Graves' Orbitopathy,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 26, no. 3, pp. 229–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. P. J. van Diest, P. van Dam, S. C. Henzen-Logmans et al., “A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG,” Journal of Clinical Pathology, vol. 50, no. 10, pp. 801–804, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Avunduk, M. C. Avunduk, H. Pazarli et al., “Immunohistochemical analysis of orbital connective tissue specimens of patients with active Graves ophthalmopathy,” Current Eye Research, vol. 30, no. 8, pp. 631–638, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. G. J. Kahaly, O. Shimony, Y. N. Gellman et al., “Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 2, pp. 422–429, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Forster, E. Otto, C. Hansen, K. Ochs, and G. Kahaly, “Analysis of orbital T cells in thyroid-associated ophthalmopathy,” Clinical and Experimental Immunology, vol. 112, no. 3, pp. 427–434, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Yang, Y. Hiromatsu, T. Hoshino, Y. Inoue, K. Itoh, and K. Nonaka, “Dominant infiltration of T(H)1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy,” Thyroid, vol. 9, no. 3, pp. 305–310, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. A. K. Eckstein, B. Quadbeck, S. Tews et al., “Thyroid associated ophthalmopathy: evidence for CD4+γδ T cells; de novo differentiation of RFD7+ macrophages, but not of RFD1+ dendritic cells; and loss of γδ and αβ T cell receptor expression,” British Journal of Ophthalmology, vol. 88, no. 6, pp. 803–808, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M.-H. Chen, M.-H. Chen, S.-L. Liao, T.-C. Chang, and L.-M. Chuang, “Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy,” Clinical Endocrinology, vol. 69, no. 2, pp. 332–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. van Steensel, D. Paridaens, M. van Meurs et al., “Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in graves' ophthalmopathy,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 3, pp. E400–E408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. W. S. Yi and X. L. Xu, “Effects of LPS-induced inflammation on differentiation of orbital pre-adipocytes in thyroid-associated ophthalmopathy,” Zhonghua Yan Ke Za Zhi, vol. 47, no. 2, pp. 156–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Bloise, L. Y. Mimura, J. Moura, and W. Nicolau, “Treatment of mild to moderate Graves' ophthalmopathy with sodium diclofenac: a pilot study,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 55, no. 9, pp. 692–695, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-H. Choi, K. O. Back, H. J. Kim, S. Y. Lee, and K. H. Kook, “Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity,” Experimental Eye Research, vol. 113, pp. 1–8, 2013. View at Publisher · View at Google Scholar · View at Scopus